转移性结直肠癌靶向治疗药物的现状与未来 期刊中心 爱唯医学网
转移性结直肠癌靶向治疗药物的现状与未来 期刊中心 爱唯医学网: 摘要：转移性结直肠癌（mCRC）的治疗在过去的8-10年获得了显著的进展，特别是用于靶向治疗的生物制剂贝伐珠单抗、西妥昔单抗和帕尼单抗，以及它们与细胞毒药物的联合使 ...
A brutal elimination round is reshaping the world's biggest market for electric cars
Chinese EV makers showing off their newest models at Auto China , which kicks off in Beijing have enjoyed generous support from the ... View article...